Advances in technology has led to a substantial decline in the cost of genome sequencing over the past few years. Increase in number of human genetic studies and rising number of clinical applications of gene expression analysis have garnered more attention due to this decline. Furthermore, introduction of advanced tools and techniques in genetics and bioinformatics that simplify RNA-Seq are expected to further reduce the cost of various gene expression studies and provide enhanced precision analysis. Reduction in computational cost has made gene expression analysis affordable for various healthcare applications along with research. Increased emphasis on targeted sequencing has further reduced the cost for expression analysis for desired genes. High competition to attain a larger share in the market is expected to further reduce the prices of sequencing over the forecast period.
Gene expression analysis is expected to witness increased adoption owing to its potential applications in screening gene-based disorders. Rapid advances in high-throughput technologies such as RNA-Sequencing, variants of PCR, and data analysis & interpretation algorithms have provided researchers with highly efficient tools to conduct expression analysis. Limitations in the usage of existing technologies along with expanding scope of application for gene expression analysis has accelerated development of novel approaches. Sets of new immune gene expression signatures are used to develop clinical research assays that investigate immune response in tumor environment. These assays are useful in assessment or prediction of treatment efficacy in clinical studies. PanCancer immune profiling panel allows researchers to generate profiles of immune response in humans for all types of cancer. Development of products with better suitability to conduct research or cater to clinical needs has propelled market growth.
The cost of gene expression analysis is expected to reduce with decline in cost of sequencing and other kits & reagents. Various players provide gene expression profiling in arrays. The per array expression profiling price is considerably low. However, the price of instruments required for high-throughput profiling of gene expression is very high. Comparison of gene-expression platforms reflects that although expensive platforms are highly efficient, their complex operability is a major barrier restraining their adoption. However, various market players and research institutes provide contract or customized expression array analysis at a substantially low cost. Thus, the market impact of this restraint is expected to reduce over the forecast period.
This section will provide insights into the contents included in this gene expression market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.
Market drivers and restraints
Key market opportunities prioritized
Latest strategic developments
Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance
GET A FREE SAMPLE
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member